Published in PLoS One on January 07, 2013
The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clin Biochem (2014) 0.90
Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue. Mol Oncol (2014) 0.83
Gene profiling and bioinformatics analyses reveal time course differential gene expression in surgically resected colorectal tissues. Oncol Rep (2014) 0.79
Effects of Cold Ischemia on Gene Expression: A Review and Commentary. Biopreserv Biobank (2016) 0.77
Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study. PLoS One (2015) 0.76
Time course analysis based on gene expression profile and identification of target molecules for colorectal cancer. Cancer Cell Int (2016) 0.75
Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality? PLoS One (2016) 0.75
The focus on sample quality: Influence of colon tissue collection on reliability of qPCR data. Sci Rep (2016) 0.75
Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patients. PLoS One (2015) 0.75
The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm. Clin Exp Metastasis (2014) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
lumi: a pipeline for processing Illumina microarray. Bioinformatics (2008) 17.19
The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol (2006) 13.13
Using GOstats to test gene lists for GO term association. Bioinformatics (2006) 12.58
EDGE: extraction and analysis of differential gene expression. Bioinformatics (2005) 3.14
Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest (2006) 1.81
Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol. Mod Pathol (2001) 1.63
Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer (2009) 1.51
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J Natl Cancer Inst (2011) 1.38
mRNA stability and cancer: an emerging link? Expert Opin Biol Ther (2007) 1.18
Tissue preparation and banking. Prog Brain Res (2006) 1.16
Organizational issues in providing high-quality human tissues and clinical information for the support of biomedical research. Methods Mol Biol (2010) 1.01
Increased expression of c-fos and c-jun in the rat small intestinal epithelium after ischemia-reperfusion injury: a possible correlation with the proliferation or apoptosis of intestinal epithelial cells. J Pediatr Surg (2006) 0.94
Gene expression in colorectal neoplasia: modifications induced by tissue ischaemic time and tissue handling protocol. Histopathology (2010) 0.93
Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Mol Oncol (2011) 0.92
Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis. Am J Transl Res (2010) 0.91
Assessing the impact of tissue devitalization time on genome-wide gene expression analysis in ovarian tumor samples. Diagn Mol Pathol (2008) 0.91
Genomic and oncoproteomic advances in detection and treatment of colorectal cancer. World J Surg Oncol (2009) 0.84
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res (2005) 11.52
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell (2011) 5.06
A MicroRNA targeting dicer for metastasis control. Cell (2010) 4.81
Limits of predictive models using microarray data for breast cancer clinical treatment outcome. J Natl Cancer Inst (2005) 3.26
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res (2007) 3.19
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res (2009) 2.52
A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics (2009) 2.27
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer (2005) 2.24
Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol (2010) 2.14
Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res (2004) 1.99
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ (2005) 1.97
Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene (2004) 1.82
Rational design of shepherdin, a novel anticancer agent. Cancer Cell (2005) 1.74
Transcriptional network dynamics in macrophage activation. Genomics (2006) 1.72
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad Sci U S A (2005) 1.70
Chromosome band 17q21 in breast cancer: significant association between beclin 1 loss and HER2/NEU amplification. Genes Chromosomes Cancer (2010) 1.63
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology (2002) 1.62
Breast cancer stem cells: an overview. Eur J Cancer (2006) 1.61
A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg (2005) 1.60
miR-21: an oncomir on strike in prostate cancer. Mol Cancer (2010) 1.54
Challenges in projecting clustering results across gene expression-profiling datasets. J Natl Cancer Inst (2007) 1.52
Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer (2009) 1.51
Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. Drug Resist Updat (2002) 1.49
Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat (2010) 1.45
Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res (2006) 1.44
Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol (2009) 1.43
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol (2009) 1.40
Gene discovery in genetically labeled single dopaminergic neurons of the retina. Proc Natl Acad Sci U S A (2004) 1.38
Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol (2007) 1.38
miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res (2012) 1.38
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer (2006) 1.38
Survivin as a target for new anticancer interventions. J Cell Mol Med (2005) 1.37
PIK3CA cancer mutations display gender and tissue specificity patterns. Hum Mutat (2008) 1.29
Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst (2005) 1.24
Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes Chromosomes Cancer (2009) 1.22
EQUAL-quant: an international external quality assessment scheme for real-time PCR. Clin Chem (2006) 1.20
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2. Oncogene (2004) 1.16
Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis (2002) 1.15
Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget (2011) 1.14
Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension. Cell Cycle (2010) 1.13
Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest (2002) 1.12
miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget (2014) 1.12
MicroRNA detection in plasma samples: how to treat heparinized plasma. J Mol Diagn (2013) 1.12
Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Crit Rev Oncol Hematol (2003) 1.11
Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literature. Dig Liver Dis (2010) 1.10
A review on biomarkers for prediction of treatment outcome in gastric cancer. Anticancer Res (2013) 1.09
9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations. Cancer (2005) 1.07
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res (2002) 1.07
Misbehaviour of XIST RNA in breast cancer cells. PLoS One (2009) 1.04
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor. Neuro Oncol (2009) 1.04
Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead. J Med Chem (2006) 1.03
Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer (2007) 1.03
VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells. Am J Pathol (2004) 1.03
Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin Cancer Res (2008) 1.02
Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat (2010) 1.02
Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One (2012) 1.01
TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res (2011) 1.00
Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. J Invest Dermatol (2003) 1.00
Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Oncogene (2004) 0.99
PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer. Breast Cancer Res Treat (2010) 0.99
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. Eur J Cancer (2005) 0.98
Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma. Cell Oncol (2007) 0.98
Bioinformatics tools for secretome analysis. Biochim Biophys Acta (2013) 0.97
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. Clin Chem (2007) 0.97
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges. Target Oncol (2011) 0.97
Multiparametric analysis of cell-free DNA in melanoma patients. PLoS One (2012) 0.97
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells. Mol Cancer Ther (2006) 0.96
Serous psammocarcinoma of the ovary: a case report and review of literature. Gynecol Oncol (2005) 0.95
Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer (2012) 0.94
Correspondence re: T. Zhang et al., Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res., 61: 8664-8667, 2001. Cancer Res (2004) 0.94
Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands. J Cell Physiol (2012) 0.93
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma. Lab Invest (2008) 0.93
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells. PLoS One (2011) 0.93
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis. Int J Biol Markers (2009) 0.93
Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas. Oncology (2003) 0.93
miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts. Antioxid Redox Signal (2013) 0.92